• Home
• advocare women's group
• Implementation Advisory Group (IAG) for the National Strategy for Drugs for Rare Diseases

Implementation Advisory Group (IAG) for the National Strategy for Drugs for Rare Diseases

4.8 (393) · $ 7.00 · In stock

Building a National Strategy for High-Cost Drugs for Rare Diseases

Stephen Frank on LinkedIn: I was thrilled to join with my counterparts from around the globe last…

Isra Jeelani Wani on LinkedIn: It was fantastic to hear from this diverse expert panel last night, which…

Aneal Khan - Implementation Advisory Group (IAG) for the National

Antibiotics December 2022 - Browse Articles

2023 Highlights in Canadian Life Sciences IP and Regulatory Law

Isra Jeelani Wani on LinkedIn: It was fantastic to hear from this diverse expert panel last night, which…

Minister of Health announces Advisory Group and three-year

Navigating multiple diseases and late diagnosis: Sylvie's Story - Canadian Rare Disease Network

Health Canada and PHAC on X: Learn about the Implementation

Frontiers Contribution of patient registries to regulatory